452 related articles for article (PubMed ID: 33087117)
1. DBCSMOTE: a clustering-based oversampling technique for data-imbalanced warfarin dose prediction.
Tao Y; Zhang Y; Jiang B
BMC Med Genomics; 2020 Oct; 13(Suppl 10):152. PubMed ID: 33087117
[TBL] [Abstract][Full Text] [Related]
2. Validation of pharmacogenetic algorithms and warfarin dosing table in Egyptian patients.
Bazan NS; Sabry NA; Rizk A; Mokhtar S; Badary O
Int J Clin Pharm; 2012 Dec; 34(6):837-44. PubMed ID: 22851439
[TBL] [Abstract][Full Text] [Related]
3. Warfarin dose requirements with different genotypes of CYP2C9 and VKORC1 for patients with atrial fibrillation and valve replacement.
Chen W; Wu L; Liu X; Shen Y; Liang Y; Zhu J; Tan H; Yang Y; Liu Q; Wang M; Liu L; Wang X
Int J Clin Pharmacol Ther; 2017 Feb; 55(2):126-132. PubMed ID: 27117036
[TBL] [Abstract][Full Text] [Related]
4. Comparative performance of pharmacogenetics-based warfarin dosing algorithms derived from Caucasian, Asian, and mixed races in Thai population.
Chumnumwat S; Yi K; Lucksiri A; Nosoongnoen W; Chindavijak B; Chulavatnatol S; Sarapakdi A; Nathisuwan S
Cardiovasc Ther; 2018 Apr; 36(2):. PubMed ID: 29243335
[TBL] [Abstract][Full Text] [Related]
5. Poor warfarin dose prediction with pharmacogenetic algorithms that exclude genotypes important for African Americans.
Drozda K; Wong S; Patel SR; Bress AP; Nutescu EA; Kittles RA; Cavallari LH
Pharmacogenet Genomics; 2015 Feb; 25(2):73-81. PubMed ID: 25461246
[TBL] [Abstract][Full Text] [Related]
6. Impact of CYP2C9 and VKORC1 genetic polymorphisms upon warfarin dose requirements in Egyptian patients with acute coronary syndrome.
Ghozlan MF; Foad DA; Darwish YW; Saad AA
Blood Coagul Fibrinolysis; 2015 Jul; 26(5):499-504. PubMed ID: 25699611
[TBL] [Abstract][Full Text] [Related]
7. Accuracy assessment of pharmacogenetically predictive warfarin dosing algorithms in patients of an academic medical center anticoagulation clinic.
Shaw PB; Donovan JL; Tran MT; Lemon SC; Burgwinkle P; Gore J
J Thromb Thrombolysis; 2010 Aug; 30(2):220-5. PubMed ID: 20204461
[TBL] [Abstract][Full Text] [Related]
8. Warfarin pharmacogenetics: development of a dosing algorithm for Omani patients.
Pathare A; Al Khabori M; Alkindi S; Al Zadjali S; Misquith R; Khan H; Lapoumeroulie C; Paldi A; Krishnamoorthy R
J Hum Genet; 2012 Oct; 57(10):665-9. PubMed ID: 22854539
[TBL] [Abstract][Full Text] [Related]
9. Prediction of sensitivity to warfarin based on VKORC1 and CYP2C9 polymorphisms in patients from different places in Colombia.
Cifuentes RA; Murillo-Rojas J; Avella-Vargas E
Biomedica; 2016 Mar; 36(1):91-100. PubMed ID: 27622442
[TBL] [Abstract][Full Text] [Related]
10. Effect of CYP2C9 and VKORC1 genetic variations on warfarin dose requirements in Indian patients.
Natarajan S; Ponde CK; Rajani RM; Jijina F; Gursahani R; Dhairyawan PP; Ashavaid TF
Pharmacol Rep; 2013; 65(5):1375-82. PubMed ID: 24399734
[TBL] [Abstract][Full Text] [Related]
11. An Ensemble Model With Clustering Assumption for Warfarin Dose Prediction in Chinese Patients.
Tao Y; Chen YJ; Xue L; Xie C; Jiang B; Zhang Y
IEEE J Biomed Health Inform; 2019 Nov; 23(6):2642-2654. PubMed ID: 30624235
[TBL] [Abstract][Full Text] [Related]
12. [Verification of accuracy of warfarin stable dose prediction models in Shandong population].
Ge Y; Qu F; Wang S; Guo X; Wang C; Liu S; Ma A; Jiang X; Tan K
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Apr; 37(4):401-404. PubMed ID: 32219822
[TBL] [Abstract][Full Text] [Related]
13. Development and Comparison of Warfarin Dosing Algorithms in Stroke Patients.
Cho SM; Lee KY; Choi JR; Lee KA
Yonsei Med J; 2016 May; 57(3):635-40. PubMed ID: 26996562
[TBL] [Abstract][Full Text] [Related]
14. Association of Genetic Polymorphisms in the VKORC1 and CYP2C9 Genes with Warfarin Dosage in a Group of Kuwaiti Individuals.
Alrashid MH; Al-Serri A; Alshemmari SH; Koshi P; Al-Bustan SA
Mol Diagn Ther; 2016 Apr; 20(2):183-90. PubMed ID: 26940072
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Maintenance Dose Predictions by Warfarin Dosing Algorithms Based on Chinese and Western Patients.
Deng J; Wang Y; An X
J Clin Pharmacol; 2023 May; 63(5):569-582. PubMed ID: 36546564
[TBL] [Abstract][Full Text] [Related]
16. Performance Evaluation of Warfarin Dose Prediction Algorithms and Effects of Clinical Factors on Warfarin Dose in Chinese Patients.
Gao W; Li Z; Chen W; Zhang S
Ther Drug Monit; 2021 Aug; 43(4):527-535. PubMed ID: 34250965
[TBL] [Abstract][Full Text] [Related]
17. The influence of CYP2C9 and VKORC1 gene polymorphisms on optimal warfarin doses after heart valve replacement.
Tatarūnas V; Lesauskaitė V; Veikutienė A; Jakuška P; Benetis R
Medicina (Kaunas); 2011; 47(1):25-30. PubMed ID: 21681008
[TBL] [Abstract][Full Text] [Related]
18. Clinical relevance of VKORC1 (G-1639A and C1173T) and CYP2C9*3 among patients on warfarin.
Teh LK; Langmia IM; Fazleen Haslinda MH; Ngow HA; Roziah MJ; Harun R; Zakaria ZA; Salleh MZ
J Clin Pharm Ther; 2012 Apr; 37(2):232-6. PubMed ID: 21507031
[TBL] [Abstract][Full Text] [Related]
19. The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen.
Sconce EA; Khan TI; Wynne HA; Avery P; Monkhouse L; King BP; Wood P; Kesteven P; Daly AK; Kamali F
Blood; 2005 Oct; 106(7):2329-33. PubMed ID: 15947090
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetics-Based Warfarin Dosing in Patients With Cardiac Valve Replacement: The Effects of CYP2C9 and VKORC1 Gene Polymorphisms.
Farzamikia N; Sakhinia E; Afrasiabirad A
Lab Med; 2017 Dec; 49(1):25-34. PubMed ID: 29182754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
